Why is Senores Pharma. falling/rising?

As of 06-Aug, Senores Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 644.00, which reflects a decrease of 32.4 points or 4.79%. The stock has underperformed its sector by 2.73% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 7.49% during this period. Additionally, the stock touched an intraday low of Rs 640.55, indicating significant selling pressure. The trading volume has also decreased, with delivery volume falling by 67.73% compared to the 5-day average, suggesting a lack of investor interest. The stock's performance over the past week shows a decline of 7.40%, while it has had a more favorable return of 13.56% over the past month.
In the broader market context, the Sensex has only fallen by 1.15% over the past week, indicating that Senores Pharmaceuticals Ltd's decline is more pronounced than the overall market. The pharmaceutical sector as a whole has also seen a decrease of 2.06%, which may be contributing to the stock's struggles. Despite a positive year-to-date return of 13.20%, the recent performance suggests that investor sentiment may be shifting negatively, particularly in light of the falling participation and liquidity concerns. Overall, the combination of sector-wide declines and specific stock performance issues has led to the current downward movement in Senores Pharmaceuticals Ltd's stock price.